Tahsin Bennur

A review on intranasal nanoparticle delivery systems for blood–brain barrier penetration in medulloblastoma therapeutics: current insights and future perspectives

Accounting for approximately 20% of all childhood central nervous system (CNS) malignancies, medulloblastoma is the most common malignant pediatric brain tumor. Current standard-of-care treatment, comprising craniospinal irradiation, adjuvant chemotherapy, and surgical resection...